244 related articles for article (PubMed ID: 27110774)
1. Amniotic Fluid Stem Cells: A Novel Source for Modeling of Human Genetic Diseases.
Antonucci I; Provenzano M; Rodrigues M; Pantalone A; Salini V; Ballerini P; Borlongan CV; Stuppia L
Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27110774
[TBL] [Abstract][Full Text] [Related]
2. Human amniotic fluid stem cells as a model for functional studies of genes involved in human genetic diseases or oncogenesis.
Rosner M; Dolznig H; Schipany K; Mikula M; Brandau O; Hengstschläger M
Oncotarget; 2011 Sep; 2(9):705-12. PubMed ID: 21926447
[TBL] [Abstract][Full Text] [Related]
3. Amniotic fluid stem cell models: A tool for filling the gaps in knowledge for human genetic diseases.
Antonucci I; Crowley MG; Stuppia L
Brain Circ; 2017; 3(3):167-174. PubMed ID: 30276320
[TBL] [Abstract][Full Text] [Related]
4. Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells.
Li C; Zhou J; Shi G; Ma Y; Yang Y; Gu J; Yu H; Jin S; Wei Z; Chen F; Jin Y
Hum Mol Genet; 2009 Nov; 18(22):4340-9. PubMed ID: 19679563
[TBL] [Abstract][Full Text] [Related]
5. Neurogenic differentiation of amniotic fluid stem cells.
Rosner M; Mikula M; Preitschopf A; Feichtinger M; Schipany K; Hengstschläger M
Amino Acids; 2012 May; 42(5):1591-6. PubMed ID: 21573873
[TBL] [Abstract][Full Text] [Related]
6. Human amniotic fluid stem cells have better potential in early second trimester of pregnancy and can be reprogramed to iPS.
Shaw SWS; Cheng PJ; Chang YL; Chao AS; Wang TH; Chang SD; Hsieh TT; Chang KH
Taiwan J Obstet Gynecol; 2017 Dec; 56(6):770-774. PubMed ID: 29241918
[TBL] [Abstract][Full Text] [Related]
7. Generation of Induced Pluripotent Stem Cells from Amniotic Fluid Cells of a Fetus with Hb Bart's Disease.
Yan JM; Li DZ
Hemoglobin; 2017 May; 41(3):198-202. PubMed ID: 28835139
[TBL] [Abstract][Full Text] [Related]
8. Amniotic fluid stem cells increase embryo survival following injury.
Prasongchean W; Bagni M; Calzarossa C; De Coppi P; Ferretti P
Stem Cells Dev; 2012 Mar; 21(5):675-88. PubMed ID: 21905920
[TBL] [Abstract][Full Text] [Related]
9. Induced pluripotent stem (iPS) cells from human fetal stem cells.
Guillot PV
Best Pract Res Clin Obstet Gynaecol; 2016 Feb; 31():112-20. PubMed ID: 26427551
[TBL] [Abstract][Full Text] [Related]
10. The Production of Pluripotent Stem Cells from Mouse Amniotic Fluid Cells Using a Transposon System.
Bertin E; Piccoli M; Franzin C; Nagy A; Mileikovsky M; De Coppi P; Pozzobon M
J Vis Exp; 2017 Feb; (120):. PubMed ID: 28287531
[TBL] [Abstract][Full Text] [Related]
11. High efficiency of reprogramming CD34⁺ cells derived from human amniotic fluid into induced pluripotent stem cells with Oct4.
Liu T; Zou G; Gao Y; Zhao X; Wang H; Huang Q; Jiang L; Guo L; Cheng W
Stem Cells Dev; 2012 Aug; 21(12):2322-32. PubMed ID: 22264161
[TBL] [Abstract][Full Text] [Related]
12. Generation of human β-thalassemia induced pluripotent stem cells from amniotic fluid cells using a single excisable lentiviral stem cell cassette.
Fan Y; Luo Y; Chen X; Li Q; Sun X
J Reprod Dev; 2012; 58(4):404-9. PubMed ID: 22498813
[TBL] [Abstract][Full Text] [Related]
13. Modeling neurogenesis impairment in Down syndrome with induced pluripotent stem cells from Trisomy 21 amniotic fluid cells.
Lu HE; Yang YC; Chen SM; Su HL; Huang PC; Tsai MS; Wang TH; Tseng CP; Hwang SM
Exp Cell Res; 2013 Feb; 319(4):498-505. PubMed ID: 23041301
[TBL] [Abstract][Full Text] [Related]
14. Reprogramming of mouse amniotic fluid cells using a PiggyBac transposon system.
Bertin E; Piccoli M; Franzin C; Nagy A; Mileikovsky M; De Coppi P; Pozzobon M
Stem Cell Res; 2015 Nov; 15(3):510-3. PubMed ID: 26987920
[TBL] [Abstract][Full Text] [Related]
15. Human amniotic fluid stem cells: a new perspective.
Siegel N; Rosner M; Hanneder M; Freilinger A; Hengstschläger M
Amino Acids; 2008 Aug; 35(2):291-3. PubMed ID: 17710362
[TBL] [Abstract][Full Text] [Related]
16. A plethora of human pluripotent stem cells.
Gao L; Thilakavathy K; Nordin N
Cell Biol Int; 2013 Sep; 37(9):875-87. PubMed ID: 23619972
[TBL] [Abstract][Full Text] [Related]
17. Induced pluripotent stem (iPS) cells from human fetal stem cells (hFSCs).
Spinelli V; Guillot PV; De Coppi P
Organogenesis; 2013; 9(2):101-10. PubMed ID: 23823661
[TBL] [Abstract][Full Text] [Related]
18. Direct Reprogramming of Human Amniotic Fluid Stem Cells by OCT4 and Application in Repairing of Cerebral Ischemia Damage.
Qin M; Chen R; Li H; Liang H; Xue Q; Li F; Chen Y; Zhang X
Int J Biol Sci; 2016; 12(5):558-68. PubMed ID: 27019637
[TBL] [Abstract][Full Text] [Related]
19. Human transgene-free amniotic-fluid-derived induced pluripotent stem cells for autologous cell therapy.
Jiang G; Di Bernardo J; Maiden MM; Villa-Diaz LG; Mabrouk OS; Krebsbach PH; O'Shea KS; Kunisaki SM
Stem Cells Dev; 2014 Nov; 23(21):2613-25. PubMed ID: 25014361
[TBL] [Abstract][Full Text] [Related]
20. Clone-derived human AF-amniotic fluid stem cells are capable of skeletal myogenic differentiation in vitro and in vivo.
Ma X; Zhang S; Zhou J; Chen B; Shang Y; Gao T; Wang X; Xie H; Chen F
J Tissue Eng Regen Med; 2012 Aug; 6(8):598-613. PubMed ID: 22396316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
